Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Inflammatory Breast Neoplasms
×
durvalumab
×
Clear all
Filters
3
NCT05795101
2025-09-19
TRUDI
Dana-Farber Cancer Institute
Phase 2
Recruiting
63 enrolled